Ledger.Open graph →

SEC Form D · filed November 21, 2025

Iambic Therapeutics, Inc

Offering

$125.0M

Sold

$99.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Jishnu Bhattacharjee · San Diego, CADirector Evan Rachlin · San Diego, CADirector Fred Manby · San Diego, CAExec · Director R. Jacob Vogelstein · San Diego, CADirector Thomas Miller · San Diego, CAExec · Director William Rastetter · San Diego, CADirector Neil Josephson · San Diego, CAExec Kurt Von Emster · San Diego, CADirector Michael Secora · San Diego, CAExec Thomas Miller · San Diego, CAExec · Director Fred Manby · San Diego, CAExec · Director Neil Josephson · San Diego, CAExec William Rastetter · San Diego, CADirector Jishnu Bhattacharjee · San Diego, CADirector Kurt Von Emster · San Diego, CADirector R. Jacob Vogelstein · San Diego, CADirector Evan Rachlin · San Diego, CADirector Shalini Sharp · New York, NYDirector Mary Tagliaferri · Emeryville, CADirector Pete Olson · San Diego, CAExec Darcy E. Higgs · Vancouver, British Columbia, CanadaExec · Director Sandra E. Mackay · Vancouver, British Columbia, CanadaDirector Todd E. Hilditch · Vancouver, British Columbia, CanadaDirector Christina Blacker · Vancouver, British Columbia, CanadaExec · Director John R. Howard · Dallas, TXDirector Pat S. Bolin · Dallas, TXDirector Jon Myers · Charlottesville, VADirector Edward Rothschild · Seattle, WAExec Shalini Sharp · DURHAM, NCDirector Michael Secora · San Diego, CAExec Mary Tagliaferri · San Diego, CADirector Pete Olson · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗